C-MAC Videolaryngoscopy Versus Direct Laryngoscopy for Percutaneous Tracheostomy (VIDLARTRAQ)

September 9, 2025 updated by: Manuel Taboada Muñiz, Hospital Clinico Universitario de Santiago

Videolaryngoscopy Versus Direct Laryngoscopy for Positioning the Tracheal Tube During Percutaneous Tracheostomy: A Randomized Controlled Trial (VIDLARTRAQUEO).

When preparing an ICU patient for percutaneous dilational tracheostomy, correct positioning of the endotracheal tube is important. During the procedure, it is possible to puncture the cuff. Tracheal tube cuff puncture can lead to failure of ventilation, loss of positive end-expiratory pressure, and possible aspiration of gastric contents blood or secretions. To minimize the risk, in our ICU, we withdraw the endotracheal tube under direct laryngoscopic vision until the cuff is visible at the vocal cords. This maneuver would also facilitate insertion of the Seldinger needle and insertion of the tracheostomy tube below the endotracheal tube. However, this maneuver to remove the endotracheal tube under direct laryngoscopy can sometimes be difficult. ICU patients present frecuently difficult laryngoscopic vision due to airway edema or secretions. In ICU, the videolaryngopy has been shown to be superior to direct laryngoscopy in visualization the upper airway, allowing better laryngoscopic vision.

Study Overview

Detailed Description

The investigators aim to compare C-MAC videolaryngoscopy versus conventional direct laryngoscopy for positioning the tracheal tube to facilitate insertion of the Seldinger needle and the tracheostomy tube below the endotracheal tube during percutaneous tracheostomy.

Study Type

Interventional

Enrollment (Estimated)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • A Coruña
      • Santiago de Compostela, A Coruña, Spain, 15866
        • Recruiting
        • University Clinical Hospital of Santiago de Compostela
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 85 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • ICU intubated patients that require a percutaneous dilational tracheostomy for clinical reasons (prolonged mechanical ventilation, airway protection or weaning failure).

Exclusion Criteria:

  • Patients younger than 18 years and older than 85 years
  • Trachea and neck abnormalities.
  • Soft tissue infection in the neck.
  • History of neck surgery.
  • Coagulation disorders or changes in coagulation parameters (platelet count < 50.000 mm3, an activated partial thromboplastin time 1.5-fold longer than the control value, and international normalized ratio > 1.5).
  • Consent refusal for participating in the trial.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Traditional direct laryngoscopy technique
Endotracheal tube will be removed before percutaneous tracheostomy using a traditional direct laryngoscopy technique.
Endotracheal tube will be removed before percutaneous tracheostomy using a laryngoscopy
Active Comparator: C-MAC videolaryngoscope technique
Endotracheal tube will be removed before percutaneous tracheostomy using a C-MAC videolaryngoscope technique.
Endotracheal tube will be removed before percutaneous tracheostomy using a C-MAC videolaryngoscopy.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Introduction of the Seldinger needle below the endotracheal tube
Time Frame: during the procedure
Percentage of patients in whom the introduction of the Seldinger needle is below the tip of the endotracheal tube
during the procedure

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Puncture of the cuff of the endotracheal tube with the Seldinger needle
Time Frame: during the procedure
Percentage of patients suffering puncture the cuff of the endotracheal tube with the Seldinger needle
during the procedure
patients who need to remove the endotracheal tube to introduce the percutaneous tracheostomy cannula
Time Frame: during the procedure
Percentage of patients who need to remove the endotracheal tube to introduce the percutaneous tracheostomy cannula
during the procedure
Laryngoscopy vision using de Modified Cormack-Lehane grade of glottic view
Time Frame: during the procedure

Differences in laryngoscopy vision using de modified Cormack-Lehane grade of glottic view

Modified Cormack-Lehane grade of glottic view:

I: full view of the glottis (better outcome) IIa: partial view of the glottis IIb: arytenoid or posterior part of the vocal cords just visible III: only epiglottis visible IV: neither glottis nor epiglottis visible (worse outcome)

during the procedure
Difficulty of removing the endotracheal tube
Time Frame: during the procedure

Differences in the difficulty of removing the endotracheal tube due to poor visualization, secretions....

Operator-assessed subjective difficulty of removing the endotracheal tube: No difficulty, mild difficulty, moderate difficulty, severe difficulty.

during the procedure
Difficulty of performing percutaneous tracheotomy
Time Frame: during the procedure
Differences in the difficulty of performing percutaneous tracheotomy Operator-assessed subjective difficulty of performing percutaneous tracheotomy: No difficulty, mild difficulty, moderate difficulty, severe difficulty.
during the procedure
Complications
Time Frame: during the ICU stay
Percentage of complications
during the ICU stay

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2022

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

June 30, 2026

Study Registration Dates

First Submitted

February 24, 2022

First Submitted That Met QC Criteria

June 9, 2022

First Posted (Actual)

June 13, 2022

Study Record Updates

Last Update Posted (Estimated)

September 15, 2025

Last Update Submitted That Met QC Criteria

September 9, 2025

Last Verified

September 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • VIDLARTRAQUEO

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Intubated Patients

Clinical Trials on Laryngoscopy technique

Subscribe